Austin Chemical continues to promote and assist in the development of life saving medications by connecting companies world-wide. As a company, we are pleased to announce a collaboration with ENDECE and their product (NDC-1308). This API has a demonstrated demyelination effect and is available for licensing. Please contact Ethan Li (ethan@austinchemical.com) for additional information.